Colon-targeted celecoxib ameliorates TNBS-induced rat colitis: A potential pharmacologic mechanism and therapeutic advantages
Keywords: Colon-specific prodrug; NF kappaB; Celecoxib; Inflammatory bowel disease; Cardiovascular toxicity;